FSHD - FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
Clinical trials for FSHD - FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new FSHD - FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY trials appear
Sign up with your email to follow new studies for FSHD - FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial hopes to slow muscle loss in FSHD
Disease control Recruiting nowThis study tests an experimental drug called AOC 1020 in 200 adults with facioscapulohumeral muscular dystrophy (FSHD), a genetic disease that causes progressive muscle weakness. Participants receive either the drug or a placebo by IV every few weeks. The goal is to see if the dr…
Matched conditions: FSHD - FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
Phase: PHASE3 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated May 11, 2026 20:46 UTC
-
New FSHD registry aims to accelerate research through patient data
Knowledge-focused Recruiting nowThis study is building a registry for people with facioscapulohumeral muscular dystrophy (FSHD). Participants share their health experiences and data through surveys, which researchers use to better understand the disease and work toward improved treatments. Anyone in the U.S. wi…
Matched conditions: FSHD - FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
Sponsor: FSHD Society • Aim: Knowledge-focused
Last updated May 17, 2026 06:51 UTC